Close mobile menu×
Close mobile menu

Hiroshi Mitsumoto, MD

Board Certifications: 
Neurology
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-1319

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor

Board Certifications

  • Neurology

Clinical Expertise

  • Neuromuscular Disease
  • ALS (Amyotrophic Lateral Sclerosis)
  • Lou Gehrig's Disease

Specialties

Education & Training

  • Tohoku University Medical School
  • Residency: Cleveland Clinic - Cleveland, OH
  • Fellowship: Cleveland Clinic - Cleveland, OH
  • Fellowship: Tufts University Hospital

Honors & Awards

  • Donald C. Mulder Award
  • Forbes Norris Award 
  • Lou Gehrig Memorial Award 

About Hiroshi Mitsumoto

Dr. Hiroshi Mitsumoto is the Wesley J. Howe Professor of Neurology at Columbia University at The Neurological Institute of New York and NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously he was on the faculty of the Cleveland Clinic Foundation where he served as Director of the ALS Center. A graduate of Toho University School of Medicine in Japan, he completed his internship at Baltimore City Hospital at Johns Hopkins, residency training in Neurology at Case Western Reserve, as well as a neuromuscular fellowship training at Tufts New England Medical Center.

Dr. Mitsumoto has devoted his clinical and research effort to the investigation of ALS in both animal models and clinical trials in patients with ALS. He is presently conducting an NIH study of Disease Markers in ALS. Dr. Mitsumoto has published and lectured, nationally and internationally extensively on the topic of ALS. He served as a member of Steering Committee of several clinical trials in ALS.

He received the Donald C. Mulder Award for achievement, leadership, and dedication in ALS from ALS Association in 1996, in 1998 he became the 5th recipient of the Forbes Norris Award from the International Alliance of ALS/MND Associations for his "compassion and love of humanity in the study, management or support of ALS/MND, and in 2000 he received the Lou Gehrig Memorial Award from the MDA. He served as Chair of the ALSA Medical Advisory Board until 1999 and now is a member of the MDA Medical Advisory Board, ALS CARE Board of Directors, and Neurology editorial board.

Academic Titles

  • Wesley J. Howe Professor of Neurology at CUMC

Administrative Positions

  • Director, ALS/PLS (Amyotrophic/Primary Lateral Sclerosis) Center
  • Director, MDA/ALS Clinic

Committee/Societies/Council Memberships

  • Chair of the ALSA Medical Advisory Board
  • MDA Medical Advisory Board Present
  • ALS CARE Board of Directors Present
  • "Neurology" editorial board Present

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Japanese

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
710 West 168th Street
New York, New York 10032
Phone:
(212) 305-1319
Fax:
(212) 305-8398
Primary

Research

Dr. Mitsumoto is presently conducting an NIH study of Disease Markers in ALS. Dr. Mitsumoto has published and extensively lectured, nationally and internationally, on the topic of ALS. He served as a member of Steering Committee of several clinical trials in ALS.

Grants

SKT IN ALS RESEARCH (P&S Industry Clinical Trial)

Dec 12 2019 - Dec 12 2024

EXPANDED ACCESS PROGRAM WITH TIRASEMTIV FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS). (P&S Industry Clinical Trial)

Oct 11 2018 - Oct 11 2023

PROMOTING RESEARCH IN PLS: CURRENT KNOWLEDGE AND FUTURE CHALLENGES (Federal Gov)

Apr 15 2019 - Mar 31 2020

EPIDEMIOLOGICAL STUDIES IN ALS WITH THE NATIONAL ALS REGISTRY (Private)

Apr 1 2019 - Mar 31 2020

PROMOTING RESEARCH IN PLS: CURRENT KNOWLEDGE AND FUTURE CHALLENGES (Private)

Jan 10 2019 - Jan 9 2020

CASE-CONTROL STUDIES NESTED IN NATIONAL ALS REGISTRY TO EVALUATE ENVIRONMENTAL RISKS (Federal Gov)

Sep 30 2015 - Sep 29 2019

PROMOTING RESEARCH IN PLS: CURRENT KNOWLEDGE AND FUTURE CHALLENGES (Private)

Apr 11 2019 - May 11 2019

ADDITIONAL ANALYSES OF THE ARREST ALS AND ALS COSMOS STUDIES IN ALS (Private)

Jan 1 2018 - Dec 31 2018

MULTI-SITE TEST-RETEST RELIABILITY AND VALIDITY STUDY OF PLS-SPECIFIC CLINIMETRIC SCALE, PLS FUNCTIONAL RATING SCALE (PLSFRS) (Private)

Jan 1 2017 - Dec 31 2018

GM604 PHASE 2A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED PILOT TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS DISEASE (ALS) (P&S Industry Clinical Trial)

Jul 25 2013 - Jul 25 2018

A PROSPECTIVE COMPREHENSIVE EPIDEMIOLOGIC STUDY IN A LARGE COHORT IN THE NATIONAL ALS REGISTRY: IDENTIFYING ALS RISK FACTORS (Federal Gov)

Sep 1 2013 - Jun 1 2018

ALS LIPODOMICS AND ALS COSMOS STUDIES (Private)

Jan 1 2017 - Dec 31 2017

PHASE 2 STUDY OF RASAGILINE FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (Federal Gov)

Sep 1 2013 - Aug 31 2017

PHASE 2 STUDY OF RASAGILINE FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (Federal Gov)

Sep 1 2013 - Aug 31 2017

2015 WINGS OVER WALL STREET RESEARCH PROJECTS PROPOSAL (Private)

Jan 1 2016 - Dec 31 2016

AMERICAN-EUROPEAN JOINT MEETING FOR ALS CLINICAL TRIAL GUIDELINES 2016 (Private)

Jan 1 2016 - Dec 31 2016

AMERICAN-EUROPEAN JOINT MEETING FOR ALS CLINICAL TRIAL GUIDELINES 2016 (Private)

Jan 1 2015 - Dec 31 2016

ALS CLINICAL TRIALS GUIDELINES (Federal Gov)

Sep 15 2015 - Sep 14 2016

CY4024-CK2017357 (P&S Industry Clinical Trial)

Jul 15 2011 - Jul 15 2016

ALS CLINICAL TRIALS GUIDELINES (Private)

Jul 1 2015 - Jun 30 2016

ALS CLINICAL TRIAL GUIDELINES 2016 MITSUMOTO CLINICAL TRIAL CONFERENCE (Private)

Jun 1 2015 - May 31 2016

INTERNATIONAL CONFERENCE TO RENEW AND UPDATE THE ALS CLINICAL TRIAL GUIDLEIINES (Private)

Jun 1 2015 - May 31 2016

223AS302 -BIB050 (P&S Industry Clinical Trial)

May 5 2011 - May 5 2016

MULTICENTER ALS COHORT STUDY OF OXIDATIVE STRESS AND DISEASE PROGRESSION (Federal Gov)

Jul 22 2009 - Apr 30 2016

NEURALTUS (P&S Industry Clinical Trial)

Apr 28 2011 - Apr 28 2016

2014 MDA WINGS OVER WALL STREET RESEARCH PROJECTS PROPOSAL (Private)

Sep 1 2014 - Aug 31 2015

BIOCHEMICAL AND MOLECULAR CHARACTERISTICS OF PRIMARY LATERAL SCLEROSIS (Private)

May 1 2013 - May 1 2015

NEUROMUSCULAR DISEASE REGISTRY (Private)

Aug 1 2014 - Dec 31 2014

INFRASTRUCTURE OF A SMALL SCREENING TRIAL CONSORTIUM - MDA ALS CLINICAL RESEARCH NETWORK (Private)

Jan 1 2012 - Dec 31 2014

2013 MDA WINGS OVER WALL STREET RESEARCH PROJECTS PROPOSAL (Private)

Sep 1 2013 - Aug 31 2014

AN OPEN-LABEL SAFETY AND TOLERABILITY STUDY EVALUATING KNS 760704 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) (P&S Industry Clinical Trial)

Aug 17 2009 - Aug 17 2014

MULTICENTER PROSPECTIVE PLS NATURAL HISTORY STUDY (Private)

Sep 1 2009 - Mar 31 2014

OXIDATIVE STRESS AND RESPIRATORY FAILURE IN ALS: A PRELIMINA RY STUDY (WOW 11-12) (Private)

Sep 1 2011 - Aug 31 2013

2012 MDA WINGS OVER WALL STREET RESEARCH PROJECTS PROPOSAL (Private)

Aug 1 2012 - Jul 31 2013

CLINICAL TRIAL OF CEFTRIAXONE IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (Federal Gov)

Dec 1 2008 - Jun 30 2013

WINGS OVER WALL STREET - ALS RESEARCH CENTER AT CUMC (Private)

Jul 1 2006 - Jan 31 2013

CLINICALLY MEANINGFUL CHANGES (CMC) SCALE IN THE MDA/ALS CLINICAL NETWORK (Private)

Jul 1 2009 - Dec 31 2012

TRIAL OF HIGH FAT/HIGH CALORIE DIET VERSUS OPTIMAL NUTRITION IN AMUOTROPHIC LATERAL SCLEROSIS (Private)

Jul 1 2009 - Jun 30 2012

NIH ALS CONFERENCE: CLINICAL RESEARCH TO FIND THE PATHOGENES IS AND CAUSE OF ALS (Federal Gov)

Apr 1 2011 - Mar 31 2012

WINGS OVER WALL STREET 2010-2011 (Private)

Nov 1 2010 - Mar 31 2012

INTERNATIONAL ALS CONFERENCE: TO PROMOTE CLINICAL RESEARCH T O FIND THE PATHOGENESIS AND CAUSE OF ALS (Private)

Mar 1 2011 - Feb 29 2012

DICHLORPHENAMIDE VS ACETAZOLAMIDE FOR PERIODIC PARALYSIS (Federal Gov)

Dec 1 2006 - Nov 30 2011

TALAMPANEL IN ALS (P&S Industry Clinical Trial)

Sep 25 2008 - Sep 1 2011

MDA CLINICAL RESEARCH NETWORK (Private)

Aug 1 2008 - Jul 31 2011

2008 WINGS OVER WALL STREET (Private)

Jul 1 2009 - Jun 30 2011

SKIN BIOPSIES FOR THE GENERATION OF ALS-SPECIFIC HUMAN EMBRY ONIC CELLS (Private)

Feb 1 2007 - Jan 31 2011

AVANIR -- 07 AVR 123 (P&S Industry Clinical Trial)

Mar 27 2008 - Oct 31 2009